PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China
· Delayed Price · Currency is CNY 33.89
-0.45 (-1.31%)
May 30, 2025, 2:45 PM CST
SHE:300725 Revenue
In the year 2024, PharmaBlock Sciences (Nanjing) had annual revenue of 1.69B CNY, down -2.12%. PharmaBlock Sciences (Nanjing) had revenue of 455.02M in the quarter ending March 31, 2025, with 20.55% growth.
Revenue
1.69B
Revenue Growth
-2.12%
P/S Ratio
3.98
Revenue / Employee
687.83K
Employees
2,455
Market Cap
6.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.69B | -36.58M | -2.12% |
| Dec 31, 2023 | 1.73B | 130.50M | 8.18% |
| Jan 1, 2023 | 1.59B | 393.07M | 32.71% |
| Dec 31, 2021 | 1.20B | 179.40M | 17.55% |
| Dec 31, 2020 | 1.02B | 360.00M | 54.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |